Biotechnology · Healthcare
Chief Accounting Officer
2026-05-01–present
Chief Accounting Officer
Damora Therapeutics, Inc. (DMRA)Equibles does not estimate personal net worth.
Get an email with a short summary when Damora Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DMRA alertsBrian Burkavage is recorded as Chief Accounting Officer at Damora Therapeutics, Inc. (DMRA) since May 1, 2026. Damora Therapeutics, Inc. reported in an 8-K filed May 4, 2026 that Brian Burkavage was appointed principal financial officer and principal accounting officer, effective May 1, 2026. Damora Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Damora Therapeutics, Inc. includes Jennifer Jarrett (CEO and Board Member), Sherwin Sattarzadeh (CEO and COO), Peter Harwin (Chairman and Board Member) and 7 others.
“On April 28, 2026, the Board appointed Brian Burkavage, the Company's current Senior Vice President, Finance, to serve as the Company's principal financial officer and principal accounting officer, effective as of the Effective Time.”
2026-05-01–present
SEC 8-K
2026-05-01–present
Biotechnology · Healthcare
Chief Accounting Officer
2026-05-01–present